Efficacy and Safety of the Combination Vitamin D With Standard of Care in Egyptian Patients With Untreated Chronic Hepatitis C

Summary

The purpose of this study is to show the superiority of a 4 weeks lead-in phase of Vitamin D followed by a 48 weeks combination of Vitamin D with PEG-IFN plus RBV in comparison with standard PEG-IFN + RBV in untreated Egyptian patients with chronic hepatitis C, on the sustained virological response (SVR) at 3 months after end of treatment (week 60).

Timeline

Start

2014-04

Primary completion

2014-04

Completion

2014-04

Outcome

Outcome not reported

Stopped: “Study objectives were considered as obsolete regarding the new AAD arrival”

Drugs

Indications